INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,330,235 | +9.3% | 52,693 | -8.7% | 0.32% | +21.1% |
| Q2 2023 | $1,217,399 | +17.0% | 57,724 | -5.6% | 0.26% | +13.5% |
| Q1 2023 | $1,040,603 | -19.3% | 61,140 | -5.3% | 0.23% | -20.7% |
| Q4 2022 | $1,289,969 | +24.0% | 64,563 | +33.8% | 0.29% | +20.8% |
| Q3 2022 | $1,040,000 | -44.4% | 48,246 | -49.1% | 0.24% | -38.9% |
| Q2 2022 | $1,869,000 | -22.7% | 94,730 | -7.9% | 0.39% | +8.6% |
| Q1 2022 | $2,418,000 | -14.5% | 102,858 | -0.9% | 0.36% | -1.9% |
| Q4 2021 | $2,829,000 | – | 103,776 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
| Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
| NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
| Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
| Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
| ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
| Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
| Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
| EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |